descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 1995 English Publisher:Ovid Technologies (Wolters Kluwer Health)Journal:Neurology, volume 45, pages 1,233-1,234 (issn: 0028-3878, eissn: 1526-632X,

Authors: Horstink, M.W.I.M.; Berger, H.J.C.; Vlasakker, C.J.W. van de;

doi: 10.1212/wnl.45.6.1233-b

pmid: 7632296

handle: 2066/21612 , 2066/189083

Cabergoline in Parkinson's disease

- Summary
- Subjects
- Metrics

Abstract

Contains fulltext : 21612___.PDF (Publisher’s version ) (Open Access)

Related Organizations

Radboud University Nijmegen
Netherlands

Keywords

Cabergoline, Dopamine Agonists, The effect of drug therapy on Parkinson"s disease., Humans, Parkinson Disease, Ergolines, De effecten van medicatie op de ziekte van Parkinson.

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average